233 related articles for article (PubMed ID: 18195709)
1. BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.
D'Arcy V; Pore N; Docquier F; Abdullaev ZK; Chernukhin I; Kita GX; Rai S; Smart M; Farrar D; Pack S; Lobanenkov V; Klenova E
Br J Cancer; 2008 Feb; 98(3):571-9. PubMed ID: 18195709
[TBL] [Abstract][Full Text] [Related]
2. Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.
Akhtar MS; Akhter N; Talat A; Alharbi RA; Sindi AAA; Klufah F; Alyahyawi HE; Alruwetei A; Ahmad A; Zamzami MA; Deo S; Husain SA; Badi OA; Khan MJ
Oncotarget; 2023 May; 14():528-541. PubMed ID: 37235839
[TBL] [Abstract][Full Text] [Related]
3. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors.
Renaud S; Pugacheva EM; Delgado MD; Braunschweig R; Abdullaev Z; Loukinov D; Benhattar J; Lobanenkov V
Nucleic Acids Res; 2007; 35(21):7372-88. PubMed ID: 17962299
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions.
El-Sharkawy NM; Radwan WM; Essa ES; Kandeel EZ; Abd El-Fattah EK; Kandil SH; Kamel AM
Cytometry B Clin Cytom; 2017 Sep; 92(5):355-360. PubMed ID: 27219508
[TBL] [Abstract][Full Text] [Related]
5. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV
Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943
[TBL] [Abstract][Full Text] [Related]
6. Expression of the cancer-testis antigen BORIS correlates with prostate cancer.
Cheema Z; Hari-Gupta Y; Kita GX; Farrar D; Seddon I; Corr J; Klenova E
Prostate; 2014 Feb; 74(2):164-76. PubMed ID: 24123052
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
Hoivik EA; Kusonmano K; Halle MK; Berg A; Wik E; Werner HM; Petersen K; Oyan AM; Kalland KH; Krakstad C; Trovik J; Widschwendter M; Salvesen HB
Oncotarget; 2014 Feb; 5(4):1052-61. PubMed ID: 24658009
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter.
Kosaka-Suzuki N; Suzuki T; Pugacheva EM; Vostrov AA; Morse HC; Loukinov D; Lobanenkov V
J Biol Chem; 2011 Aug; 286(31):27378-88. PubMed ID: 21659515
[TBL] [Abstract][Full Text] [Related]
10. The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis.
D'Arcy V; Abdullaev ZK; Pore N; Docquier F; Torrano V; Chernukhin I; Smart M; Farrar D; Metodiev M; Fernandez N; Richard C; Delgado MD; Lobanenkov V; Klenova E
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5978-86. PubMed ID: 17062669
[TBL] [Abstract][Full Text] [Related]
11. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
12. MAGEA1 inhibits the expression of BORIS via increased promoter methylation.
Zhao J; Wang Y; Liang Q; Xu Y; Sang J
J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011
[TBL] [Abstract][Full Text] [Related]
13. The structural complexity of the human BORIS gene in gametogenesis and cancer.
Pugacheva EM; Suzuki T; Pack SD; Kosaka-Suzuki N; Yoon J; Vostrov AA; Barsov E; Strunnikov AV; Morse HC; Loukinov D; Lobanenkov V
PLoS One; 2010 Nov; 5(11):e13872. PubMed ID: 21079786
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
[TBL] [Abstract][Full Text] [Related]
15. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE
Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099
[TBL] [Abstract][Full Text] [Related]
16. BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P
PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816
[TBL] [Abstract][Full Text] [Related]
17. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer.
Klenova EM; Morse HC; Ohlsson R; Lobanenkov VV
Semin Cancer Biol; 2002 Oct; 12(5):399-414. PubMed ID: 12191639
[TBL] [Abstract][Full Text] [Related]
18. BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma.
Chen K; Huang W; Huang B; Wei Y; Li B; Ge Y; Qin Y
Genet Test Mol Biomarkers; 2013 Feb; 17(2):160-5. PubMed ID: 23237599
[TBL] [Abstract][Full Text] [Related]
19. The evolution of epigenetic regulators CTCF and BORIS/CTCFL in amniotes.
Hore TA; Deakin JE; Marshall Graves JA
PLoS Genet; 2008 Aug; 4(8):e1000169. PubMed ID: 18769711
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Msx2 gene expression by steroid hormones in human nonmalignant and malignant breast cancer explants cultured in vitro.
Malewski T; Milewicz T; Krzysiek J; Gregoraszczuk EL; Augustowska K
Cancer Invest; 2005; 23(3):222-8. PubMed ID: 15945508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]